Home > Adults > Neurology >

Neurophysiology

Checked: 01-07-2025 by Jenny Henry Next Review: 30-06-2027

Clinical Guidelines

There are local guidelines on the use of Clinical Neurophysiology which give advice on appropriate (and inappropriate) referrals to their service. Referrals are triaged by the neurophysiology team and may be returned if an investigation is not felt to be indicated.

The Neurophysiology service offers direct GP access to the following tests:

Nerve conduction studies (NCS) and electromyography (EMG).

They do not accept direct GP referrals for Electroencephalopathy (EEG)

If clinicians are unsure about the appropriateness of a referral, they are encouraged to contact one of the consultants to discuss a case:

Dr Agyepong Oware	Monday & Friday	Agyepong.Oware@nbt.nhs.uk	0117 4141050
Dr Nick Kane	Tuesday, Wednesday & Thursday	Nick.Kane@nbt.nhs.uk.
Dr Sabine Klepsch	Wednesday and Thursday	Sabine.Klepsch@nbt.nhs.uk
Dr Sona Janackova	Monday-Friday	Clinicalneurophysiology@uhbw.nhs.uk	0117 3428254

Referral

NBT

Nerve conduction studies at NBT (Southmead Hospital) can be accessed through e-Referral (under Diagnostic Physiological Measurement - Neurophysiology-Nerve Conduction Studies).

UHBW

Nerve conduction studies at UHBW (BRI) are currently accessible via ICE (search on 'neurophysiology' to bring up referral form)

GPs with access to ICE should refer via this route. For those GPs without access to the ICE system, email: clinicalneurophysiology@uhbw.nhs.uk.

**Coming soon**

From 1st August 2025, nerve conduction studies at BRI will also be available via eRS (under Diagnostic Physiological Measurement - Neurophysiology-Nerve Conduction Studies). Access via ICE will cease on 1st September 2025.

Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.